Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Gandra SR, Villa G, Fonarow GC, Lothgren M, Lindgren P, Somaratne R, et al.

Clin Cardiol. 2016; 39(6): 313-20
DOI: 10.1002/clc.22535